Colon Cancer Treatment - Avastin Falls Short in Colon Cancer Trial - Star News Online
Avastin Falls Short in Colon Cancer Trial - Star News Online
The drug Avastin failed to prevent colon cancer from recurring by a significant amount in a clinical trial, the drug s manufacturer, Genentech, said early Wednesday. The results of the trial had been closely watched because a success would have
Aspirin for forty somethings could cut cancer risk - News-Medical.Net
In a detailed review of all the available evidence, Cancer Research UK scientists suggest that taking aspirin at an age before cancer begins to develop - and for at least 10 years - would maximise the drug’s potential to prevent cancer. Previous
Phase III C-08 Study Of Avastin In Early-Stage Colon Cancer Did Not - Medical News Today
Genentech, Inc. announced that a Phase III study of Avastin (bevacizumab) plus chemotherapy following surgery in patients with early-stage (adjuvant) colon cancer (NSABP C-08) did not meet its primary endpoint of reducing the risk of cancer
Hormone Therapy Offers Potential Protective Effect Against Colon - Science Daily
ScienceDaily (Apr. 27, 2009) In a large study, a national team of researchers led by Mayo Clinic scientists observed that self-reported use of hormone therapy was associated with a significantly lower colorectal cancer risk. However, the